Everest Medicines Ltd
HKEX:1952
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
14.54
50.3
|
Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Gross Margin
Everest Medicines Ltd
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
Country | CN |
Market Cap | 15B HKD |
Gross Margin |
76%
|
Country | FR |
Market Cap | 6T USD |
Gross Margin |
0%
|
Country | US |
Market Cap | 310.2B USD |
Gross Margin |
67%
|
Country | US |
Market Cap | 142B USD |
Gross Margin |
60%
|
Country | US |
Market Cap | 115B USD |
Gross Margin |
78%
|
Country | US |
Market Cap | 101.6B USD |
Gross Margin |
86%
|
Country | US |
Market Cap | 94.1B EUR |
Gross Margin |
76%
|
Country | AU |
Market Cap | 134.4B AUD |
Gross Margin |
52%
|
Country | US |
Market Cap | 78.5B USD |
Gross Margin |
87%
|
Country | US |
Market Cap | 39.3B EUR |
Gross Margin |
75%
|
Country | NL |
Market Cap | 36B EUR |
Gross Margin |
89%
|
Everest Medicines Ltd
Glance View
Everest Medicines Ltd., a biopharmaceutical company headquartered in Shanghai, is carving its niche in the competitive terrain of healthcare innovation. Founded in 2017, the company was envisioned as a bridge connecting groundbreaking global therapies with the Asian market, particularly China, where the demand for advanced medical solutions is substantial. While the international pharmaceutical landscape is often dominated by industry giants, Everest distinguishes itself through strategic collaborations and licensing agreements with several leading global biotech companies. These partnerships allow Everest to bring transformative therapies, particularly in oncology, immunology, and infectious diseases, to regions where they are most needed. The way Everest Medicines operates is not entirely unconventional but certainly strategic. By licensing late-stage clinical assets, the company bypasses the early, most risky, stages of drug development. Their revenue model hinges on successfully bringing these licensed drugs through regulatory pathways and then commercializing them across China and other Asian markets. With a focus on high-impact, high-need areas, Everest aims to address substantial gaps in healthcare provision while capitalizing on the potentially lucrative Asian pharmaceutical market. This model allows Everest to exploit its deep understanding of both international drug development and local regulatory landscapes to streamline the introduction of advanced therapies, thus positioning itself as a critical player in the regional healthcare ecosystem. This approach not only mitigates initial risks but also aligns its growth with the increasing healthcare demands and policy shifts favoring innovation in Asia.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Everest Medicines Ltd's most recent financial statements, the company has Gross Margin of 75.7%.